Effects of oral adsorbent AST-120 (Kremezin(R)) on progression of chronic renal failure (CRF); A randomized controlled study.

被引：0
|
作者：
Owada, A
Shiigai, T
Nakao, M
机构：
[1] TORIDE KYODO GEN HOSP,DEPT INTERNAL MED,IBARAKI,OSAKA,JAPAN
[2] KUREHA CHEM IND CO LTD,TOKYO,JAPAN
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A0753 / A0753
页数：1
相关论文
共 50 条
  • [31] Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120
    Six, Isabelle
    Gross, Priscilla
    Remond, Mathieu C.
    Chillon, Jean Marc
    Poirot, Sabrina
    Drueke, Tilman B.
    Massy, Ziad A.
    ATHEROSCLEROSIS, 2015, 243 (01) : 248 - 256
  • [32] AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases
    Ueda, Haruhiko
    Shibahara, Nobuhisa
    Takagi, Shizuko
    Inoue, Toru
    Katsuoka, Yoji
    THERAPEUTIC APHERESIS AND DIALYSIS, 2007, 11 (03) : 189 - 195
  • [33] ORAL ADSORBENT AST-120 DECREASE THE CHRONIC CYCLOSPORIN NEPHROTOXICITY BY DECREASING OXIDATIVE STRESS
    Yang, Chul Woo
    Kim, Su Hyun
    Piao, Sangguo
    Ghee, Jung Yeon
    Song, Ji Hyun
    TRANSPLANT INTERNATIONAL, 2009, 22 : 344 - 344
  • [34] Possible involvement of nuclear factor-κB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure
    Komiya, T
    Miura, K
    Tsukamoto, J
    Okamura, M
    Tamada, S
    Asai, T
    Tashiro, K
    Kuwabara, N
    Iwao, H
    Yoshikawa, J
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2004, 13 (01) : 133 - 138
  • [35] The oral adsorbent AST-120 attenuates the progression of hyperlipidemia and glomerulosclerosis in spontaneous hypercholesterolemic rats (SHCRs)
    Sato T.
    Miyazaki S.
    Sakemi T.
    Mohri S.
    Clinical and Experimental Nephrology, 2000, 4 (1) : 18 - 23
  • [36] Effects of oral carbonic adsorbent (AST-120) on kidney of early-stage chronic kidney disease rats
    Tan, Xiao
    He, Jianqiang
    Cao, Xuesen
    Zou, Jianzhou
    Liu, Hong
    Ding, Xiaoqiang
    RENAL FAILURE, 2015, 37 (02) : 337 - 342
  • [37] A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction
    Cha, Ran-hui
    Kang, Shin Wook
    Park, Cheol Whee
    Cha, Dae Ryong
    Na, Ki Young
    Kim, Sung Gyun
    Yoon, Sun Ae
    Han, Sang Youb
    Chang, Jae Hyun
    Park, Sue K.
    Lim, Chun Soo
    Kim, Yon Su
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (04): : 559 - 567
  • [38] Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease
    Hatakeyama, Shingo
    Yamamoto, Hayato
    Okamoto, Akiko
    Imanishi, Kengo
    Tokui, Noriko
    Okamoto, Teppei
    Suzuki, Yuichiro
    Sugiyama, Naoaki
    Imai, Atsushi
    Kudo, Shigemasa
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Koie, Takuya
    Kaminura, Noritaka
    Saitoh, Hisao
    Funyu, Tomihisa
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2012, 2012
  • [39] Possible involvement of nuclear factor-kappa B inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure
    Komiya, T
    Tamada, S
    Tashiro, K
    Asai, T
    Kuwabara, N
    Hayama, T
    Kaneda, N
    Iwao, H
    Miura, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 113P - 113P
  • [40] Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease
    Takahashi, Tomohiko
    Reed, Shelby D.
    Schulman, Kevin A.
    NEPHROLOGY, 2008, 13 (05) : 419 - 427
12345